Browsing tag: Active Pharmaceutical Ingredients

Symbiotec Pharmalab IPO Review

23rd August 2026

Symbiotec Pharmalab Limited, a company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients, plans to raise INR 1,757 crore through an IPO. [Fresh Issue ₹150 Cr + OFS ₹1,607 Cr] Symbiotec Pharmalab IPO price: ₹938–₹988 per share   Symbiotec Pharmalab: History The Company was incorporated as Symbiotec Pharmalab Private Limited as a private limited company under the Companies Act, 1956, on September 20, 2002. The Company was

By Vishal Dalwadi
No Comment
Read more

Anlon Healthcare IPO – Review

24th August 2025

Anlon Healthcare Limited, a research-intensive manufacturer of Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, plans to raise ₹121 Crore through an IPO. [Fresh Issue ₹ 121 Cr + OFS NIL] Anlon healthcare ipo price is ₹ 86 - ₹ 91 per share   Anlon Healthcare: History The Company was originally incorporated as Anlon Ventures Private Limited, a private limited company under the Companies Act, 1956, on November 19, 2013. The Company was converted into a public limited

By Vishal Dalwadi
No Comment
Read more

Ipca Laboratories Limited: Value Pick Stock April 2020

3rd April 2020

Ipca Laboratories Limited (IPCA) is a fully-integrated Indian pharmaceutical company manufacturing and marketing over 350 formulations and 80 Active Pharmaceutical Ingredients (APIs) covering various therapeutic segments. Ipca Laboratories Limited: Profile Ipca Laboratories was founded by a group of businessmen and medical professionals in the year 1949 under the name of The Indian Pharmaceutical Combine Association Limited. The name of the organization was changed to Ipca Laboratories Ltd

By Vishal Dalwadi
No Comment
Read more

Value Pick Of The Month

FOLLOW FINBLAB ON TWITTER